Elsevier

Life Sciences

Volume 52, Issue 24, 1993, Pages 1917-1924
Life Sciences

Inhibition of human monocyte TNF production by adenosine receptor agonists

https://doi.org/10.1016/0024-3205(93)90632-DGet rights and content

Abstract

Adenosine receptor agonists and agents enhancing pericellular concentrations of adenosine possess antiinflammatory properties. In the present study, we found that R-phenylisopropyladenosine (R-PIA), 5'-N-ethylcarboxamido adenosine (NECA), other agonists of adenosine receptors and dipyridamole, an adenosine uptake inhibitor, inhibited tumor necrosis factor (TNF) production by endotoxin-stimulated human monocytes in a concentration- dependent manner with no inhibition of interleukin-6. The rank order of agonist potency is characteristic of neither A1 nor A2 receptors and suggests the involvement of another receptor subtype. The effect of R-PIA on TNF was in part abolished by the antagonist 8-sulfophenyltheophylline. In endotoxin-treated rats, R-PIA pretreatment (2.5 mg/kg) reduced serum TNF levels by 98%, with no modification of serum IL6 levels. TNF inhibition could be an important mechanism by which adenosine analogs exert their antiinflammatory action.

References (42)

  • C.A. Dinarello

    Blood

    (1991)
  • R. Schindler et al.

    Blood

    (1990)
  • T. Hirano et al.

    Immunol. Today

    (1990)
  • B. Henderson et al.

    Trends in Pharmacol. Sci.

    (1992)
  • C.A. Dinarello et al.

    Immunol. Today

    (1991)
  • D.E. Griswold et al.

    Biochem. Pharmacol.

    (1991)
  • E. Corsini et al.

    Int. J. Immunopharmacol.

    (1992)
  • M.B. Hansen et al.

    J. Immunol. Methods

    (1989)
  • B.B. Fredholm et al.

    Trends Pharmacol. Sci.

    (1988)
  • R.M. Strieter et al.

    Biochem. Biophys. Res. Com.

    (1988)
  • M.A. Ventura et al.

    Biochem. Pharmacol.

    (1990)
  • A. Mantovani et al.

    Immunol. Today

    (1989)
  • B. Beutler et al.

    Ann. Rev. Immunol.

    (1990)
  • C.A. Dinarello

    Eur. Cytokine Network

    (1992)
  • B. McDonald et al.

    Arthritis Rheum.

    (1988)
  • E. Kovacs et al.

    Immunol.

    (1988)
  • J. Han et al.

    J. Exp. Med.

    (1990)
  • E.P. Sampaio et al.

    J. Exp. Med.

    (1991)
  • A. Severn et al.

    J. Immunol.

    (1992)
  • K.A. Jacobson et al.

    J. Med. Chem.

    (1992)
  • P.G. Green et al.
  • Cited by (109)

    • Extracellular nucleotides and nucleosides as signalling molecules

      2019, Immunology Letters
      Citation Excerpt :

      The end result is the activation of anti-inflammatory and immune suppressive responses, aimed at promoting healing and finally restoring tissue homeostasis [57]. Adenosine acts as an immunosuppressant by inhibiting functions of several immune cell populations such as T and B lymphocytes, NK cells, dendritic cells, monocytes, and macrophages [58–60]. Finally, G-protein-coupled receptors (GPCRs) named P0, activated by adenine base but not adenosine, have been discovered more recently.

    • Peripheral adenosine levels in euthymic patients with bipolar disorder

      2016, Psychiatry Research
      Citation Excerpt :

      Decreased serum adenosine levels in bipolar disorder compared with controls indicates a systemic reduction of a neuroprotective agent. One mechanism of adenosine neuroprotection is via a reduction of microglia and macrophages activation (central and peripheral action), thereby reducing pro-inflammatory cytokines, chemokines and nitric oxide (Bischofberger et al., 1997; Cronstein, 1994) besides potently inhibiting TNF-α production (Le Vraux et al., 1993; Schubert et al., 1997). Likewise, a pro-inflammatory profile is well accepted as an important part of bipolar disorder pathophysiology (Jakobsson et al., 2015; Réus et al., 2015), including the presence of microglial activation (Stertz et al., 2013) and increased TNF-α production (Munkholm et al., 2013).

    • Adenosine modulates LPS-induced cytokine production in porcine monocytes

      2013, Cytokine
      Citation Excerpt :

      The inhibitory effect of adenosine on TNF-α occurred also at mRNA level. The ability of adenosine to modulate TNF-α production has been well known for a long time in human monocytes [17,18] and is consistent with the proclaimed general anti-inflammatory actions of extracellular adenosine. On the other hand, the present study demonstrates a dose-dependent stimulatory effect of adenosine on pro-inflammatory chemokine IL-8 production, which might imply that the effect of adenosine on monocytes is more multilayered and not strictly anti-inflammatory.

    View all citing articles on Scopus
    View full text